ADMP Stock Falls 50%: FDA Rejects Opioid Overdose Treatment Zimhi
ADMP is one of the biggest losers in the health sector on Monday after Adamis Pharmaceuticals Corp (NASDAQ:ADMP) said that the US Food and Drug Administration did not approve its opioid overdose treatment, Zimhi. Major ... [Read]